Alignment Healthcare Overview
Valuation check: ALHC's P/E ratio is 41.85, above the Finance sector average of 15.93.
Get informed when a big investor buys or sells
+ Follow41.85
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Alignment Healthcare's p/e ratio stands at 41.85. That is above the Finance sector average of 15.93. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Alignment Healthcare sits higher the Finance benchmark (15.93) with a P/E ratio of 41.85. That is roughly 162.7% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 41.85 is attractive depends on Alignment Healthcare's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Alignment Healthcare's P/E ratio evolved across reporting periods, while the comparison chart places ALHC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Finance, P/E ratio is commonly used to spot outliers. Alignment Healthcare's reading of 41.85 (sector avg 15.93) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
